On Twitter, anti-vaccination sentiments spread more easily than pro-vaccination sentiments
On Twitter, a popular microblogging and social-networking service, statements about vaccines may have unexpected effects—positive messages may backfire, according to a team of Penn State University researchers ...
Inventors scoop European awards
Inventors of a new drug for hepatitis B treatment, a tailor-made hearing aid and improved high speed data transfer were awarded a coveted European Patent Office prize here Thursday.
16th-century Korean mummy provides clue to hepatitis B virus genetic code
The discovery of a mummified Korean child with relatively preserved organs enabled an Israeli-South Korean scientific team to conduct a genetic analysis on a liver biopsy which revealed a unique hepatitis ...
Adapting personal glucose monitors to detect DNA
An inexpensive device used by millions of people with diabetes could be adapted into a home DNA detector that enables individuals to perform home tests for viruses and bacteria in human body fluids, in food ...
Gov't to adopt strict new limits on chimp research
(AP) -- Days in the laboratory are numbered for chimpanzees, humans' closest relative.
Group urges gov't to strictly limit chimp research
Chimpanzees should hardly ever be used for medical research, a prestigious scientific group told the government Thursday - advice that means days in the laboratory may be numbered for humans' closest relatives.
Routine antenatal screening for hepatitis B in an urban NYC population
According to new research at Columbia Presbyterian Medical Center, high rates of chronic hepatitis B infection (HBV) are found in pregnant minority and immigrant women in the New York City area, and most of them do not receive ...
Nobel winner, NASA astrobiologist Blumberg dies
Baruch Blumberg, who won the Nobel Prize for helping identify the Hepatitis B virus and who served as the first chief of NASA's Astrobiology Institute, has died at the age of 85, NASA said Wednesday.
Entry inhibitors show promise as drugs with new MOA for treatment of HBV and HDV infection
Promising new viral hepatitis data presented today at the International Liver CongressTM show that entry inhibitors --a new mechanism of action for drugs to treat viral hepatitis -- could provide the first new hepatitis B ...
Sequential treatment with entecavir and lamivudine results in rebound of hepatitis B virus
A two-year trial of entecavir followed by lamivudine (LAM) in patients with chronic hepatitis B virus (HBV) infection resulted in a virologic rebound rate of 24% and 12% drug-resistance rate. Patients who continued on entecavir ...
HBV infection decreases risk of liver metastasis in colorectal cancer patients
A research team from China evaluated the effect of hepatitis B virus (HBV) infection on liver metastasis of colorectal cancer. The study showed that HBV infection decreases the risk of liver metastasis in patients with colorectal ...
VA halts surgeries at St. Louis hospital
(AP) -- The VA Medical Center in St. Louis halted surgeries indefinitely this week after a regular inspection showed possible contamination of equipment, the hospital's medical director said Thursday.
Boosting body's immune response may hold key to HIV cure
Australian scientists have successfully cleared a HIV-like infection from mice by boosting the function of cells vital to the immune response.
Why humans are more sensitive to certain viruses: Primate immune system differences identified
The greater susceptibility of humans to certain infectious diseases when compared to other primates could be explained by species-specific changes in immune signaling pathways, a University of Chicago study finds. The first ...